By Tony Doyle, Managing Director, Qbtech Ltd
The publication of the final report by the Independent ADHD Taskforce marks a pivotal moment in the transformation of ADHD care across England. At Qbtech, we welcome the Taskforce’s recommendations and share its mission to improve access, experience, and outcomes for people living with ADHD.
As a company dedicated to developing objective, digital tools for ADHD assessment, we are encouraged by the report’s call for upstream, preventative strategies and the greater use of technology to reduce waiting times and improve equity of access. These principles are at the heart of our innovation.
Our NICE-recommended (1) QbTest is already widely used across the NHS, while our SaaS-based QbCheck enables remote testing at home or in-clinic with equivalent sensitivity and specificity (2). We are in advanced development and testing stages of a smartphone version that uses machine learning (3) with the aim of further democratizing access to objective ADHD testing.
Alongside this, we are developing a pre-assessment product to streamline the collection and initial interpretation of subjective and objective patient data. It aims to significantly reduce administrative burden and help ensure patients arrive at appointments fully worked-up, ready for triage and treatment.
We believe that by digitizing ADHD assessments and making them more accessible, we can support the NHS and the private sector alike in delivering faster, fairer, and more efficient ADHD care. We look forward to working with NHS England, integrated care boards, providers, clinicians, and patient groups to help implement the Taskforce’s recommendations and build a future where ADHD care is timely, equitable, and evidence-based.
For further information, contact the Qbtech team here.
What is the ADHD Taskforce?
Established and funded by NHS England, the Independent ADHD Taskforce is a group of 15-20 experts tasked with reviewing ADHD care across England for both children and adults. This interim report outlines current challenges and provides actionable recommendations for the NHS to address growing demand, reduce waitlists, and improve equity in care.
Citations
- NICE Diagnostic Guidance DG60; Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) https://www.nice.org.uk/guidance/dg60
- Fredrik Ulberstad, Hans Boström, Mira-Lynn Chavanon, Martin Knollmann, James Wiley, Hanna Christiansen, Lisa B. Thorell Objective measurement of attention deficit hyperactivity disorder symptoms outside the clinic using the QbCheck: Reliability and validity. International Journal of Methods in Psychiatric Research https://doi.org/10.1002/mpr.1822
- Nuria Casals, Simon Larsson, Mikkel Hanson. Machine learning on a smartphone-based CPT for ADHD prediction. Frontiers in Psychiatry https://doi.org/10.3389/fpsyt.2025.1564351